Skip to main content
Back

Greater China Equities: Driving the next leg of innovation 

31 December 2025

Kai Kong Chay, Senior Portfolio Manager, Greater China Equities

Wenlin Li, Senior Portfolio Manager, Greater China Equities

Ben Yu, Head of Equities, Taiwan Region

Greater China equity markets registered a strong equity rally in 2025 to date, driven by technology breakthroughs, demand for localisation, go-global demand, and upward earnings growth revisions. We reiterate a positive view on Greater China equity markets going into 2026 as we believe Chinese Mainland and Taiwan are well-positioned to drive high-quality growth to the next level.

Summary:

  1. We reiterate a positive view on Greater China equity markets going into 2026, supported by attractive valuations and resilient fund flows.
  2. We believe there are various investment opportunities for Chinese Mainland, notably in technology, industrials, renewable energy, healthcare, and new/niche/experienced consumption.
  3. For the Taiwan region, we expect further corporate earnings expansion in 2026, with structural growth opportunities in foundries, outsourced semiconductor assembly and test (OSAT) supply chain, thermal cooling solutions and power supply solutions.

 

Download the full version

  • 2026 Mid-year outlook: Greater China Equities

    Greater China equity markets showed divergent trends in the first half of 2026, with China A-shares and the Taiwan Taiex index registering strong gains driven by resilient technology exports amid global demand for artificial intelligence (AI). Meanwhile, the MSCI China market pulled back, weighed by commerce subsidies amid fierce competition in food delivery and rising AI capital expenditure, which we believe have already been priced in. In this mid-year Outlook, we highlight five positive drivers for China and Hong Kong equities in the second half of the year. Furthermore, the team explains why it believes the Taiwan region’s technology sector should continue to enjoy positive momentum.

    Read more
  • 2026 Mid-Year Outlook Series: Asia Equities ex-Japan

    Asia equities ex-Japan continued the significant momentum from 2025 with strong performance throughout the first half of the year. Amid numerous catalysts, June Chua, Head of Asia Equities outlines in this Mid-Year Outlook why she is constructive on the asset class for the remainder of 2026. Positive drivers include: potential geopolitical resolution in the Middle East and lower energy costs, supportive earnings and valuations, and differentiated growth drivers across the region.

    Read more
  • 2026 Global healthcare equities outlook: Innovation supports healthcare’s long term case

    Global healthcare equities showed resilience amid 2025 volatility. The defensive characteristics, coupled with remarkable therapeutic innovations in the biopharmaceutical, MedTech, and tools sub-segments of this sector, will continue to be rewarded with capital appreciation over a full market cycle. Current valuations relative to the broader market make for an attractive entry point today, and periods like this tend to lead to outperformance for healthcare stocks over the long term.

    Read more
See all

Help us to serve you betterClick here to find out how you can update your Information today!

View more